Dai Takamatsu
Papers
4
Total Citations
31
H-Index
3
About
Dai Takamatsu is a urologic surgeon and researcher whose work focuses on optimizing outcomes in robot-assisted radical prostatectomy (RARP), particularly in the domains of oncologic control and post-surgical quality of life. His research has critically examined the trade-offs inherent in nerve-sparing techniques, demonstrating how these procedures influence positive surgical margin rates and biochemical recurrence—a key predictor of cancer progression. In a 2022 study (12 citations), he provided granular data on margin location and recurrence risk, helping to refine surgical decision-making. Takamatsu has also investigated the impact of extended pelvic lymph node dissection on early urinary incontinence, a common and distressing side effect, and developed a novel nomogram to predict biochemical recurrence-free survival, offering clinicians a practical tool for patient counseling. His recent work includes a pioneering report on salvage RARP following carbon ion radiotherapy (2024), a challenging scenario with limited published data. With multiple high-impact contributions in just a few years, Takamatsu is establishing himself as a thoughtful voice in the evolution of prostate cancer surgery, balancing aggressive cancer control with functional preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4